Oklo to advance Groves 2 Forge as part of DOE launch pad selection
OKLO•Oklo will advance Groves 2 Forge as part of the U.S. Department of Energy’s Nuclear Energy Launch Pad selection. The company plans to transition it to commercial-scale isotope production with NRC licenses, initially producing lutetium-177 for targeted cancer treatments.
1. Forge isotope plans
Oklo said it will advance Groves 2 Forge as part of the U.S. Department of Energy’s Nuclear Energy Launch Pad selection. The company plans to transition the facility to commercial-scale isotope production with NRC licenses, initially producing lutetium-177 for targeted cancer treatments.
